Therefore, differences in CD18+CD11c− adhesion molecules in severe CFS/ME patients may be associated with the reduced NK cell cytotoxic activity found in the illness [5, 10, 11]. This evidence concerns the gene ITGB2 and myalgic encephalomeyelitis/chronic fatigue syndrome.